Please login to the form below

Not currently logged in
Email:
Password:

acquisitions

This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

The acquisition includes TeneoTwo’s phase 1 clinical-stage T-cell engager. In a new deal valued at up to $1.27bn, AstraZeneca (AZ) has acquired biotechnology firm TeneoTwo. ... The agreement includes the acquisition of TeneoTwo’s phase 1

Latest news

More from news
Approximately 203 fully matching, plus 1,302 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 75 fully matching, plus 99 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 124 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 15 fully matching, plus 121 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....